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MATERIALS AND METHODS
The results of diagnosis by colposcopy, cytology and target biopsy in 91 patients diagnosed by conization using an 8 block serial section of the cervix as having carcinoma in situ and 39 patients diagnosed as having microinvasive carcinoma were compared with regard to the location of the lesions. Colposcopy was performed by applying 3% acetic acid solution to the portio vaginalis and the cervical canal after taking off the cervical mucus, and any abnormal colposcopical findings were then recorded. Cytology entailed performing Papanicolaou staining after scraping the portio and cervical canal with a wooden spatula, carcinoma in situ and microinvasive carcinoma could then be determined cytologically. Target biopsy entailed colposcopic investigation for abnormalities, obtaining two or three tissue samples and performing HE staining. Definitive therapy consisted of abdominal or vaginal simple hysterectomy for cases of carcinoma in situ and extended hysterectomy for cases of microinvasive carcinoma. Diagnostic criteria for carcinoma in situ were as follows: (a) lateral invasion or mesenchymolysis, (b) lots of abnormal mitosis, or (c) lack of differentiation, replacement of the whole epithelial layer with cells having lost their polarity, in cases where abnormal epithelium of the uterine cervix does not exceed the basement membrane (Noda et al. 1976) . A depth of invasion into the stroma measured from the shallowest basement membrane directly above the area of the invasion was diagnostic for microinvasive carcinoma when it was less than 3 mm. Cases with a depth of invasion less than 3 mm but with a pattern of invasion indicating confluent invasion or vessel permeation were included among the group with microinvasive carcinoma.
RESULTS
The location of the cervical lesion diagnosed with conization as carcinoma in situ or microinvasive carcinoma is classified as shown in Table 1 with respect to the external os of the uterus.
Cases of lesions only external to the external os of the uterus, in other words, lesions of the ectocervix were designated as A-type; lesions located both internal and external to the external os of the uterus were designated as B-type; and lesions only internal to the external os, limited to the endocervix, designated as C-type. B-type lesions of both carcinoma in situ and microinvasive carcinoma were the commonest, followed by A-type lesions of carcinoma in situ and C-type lesions of microinvasive carcinoma.
The average age of the patients was 38.4 years, 44.4 years and 48.9 years for the A-, B-, and C-type lesions, respectively (Table 1) . A variety of residual diseases in samples from hysterectomies performed subsequently to conization are shown in Tables 2 and 3 . One A-type case, shown in Table 2 , had residual carcinoma in situ which was located in the vaginal wall. Two B-type cases had dysplasia remaining deep within the cervical canal . Among the 91 cases of carcinoma in situ diagnosed with conization 88 (97%) showed no residual diseases in hysterectomy samples . In contrast, among the cases diagnosed by conization as microinvasive carcinoma , hysterectomy samples showed dysplasia remaining in 6 cases, carcinoma in situ remaining in 1 case and microinvasive carcinoma remaining in 7 cases; all of these were located within the cervical canal . In other words, 25 of these 39 patients (64%) showed no residual diseases at hysterectomy. The relationship between abnormal colposcopic findings and the location of the lesions is expressed in Table 4 . In cases of carcinoma in situ or microinvasive carcinoma located in the ectocervix (Types A and B), the rate of abnormal colposcopic findings was high, approximately 90%. In contrast, C-type cases, where the lesion was limited to the endocervix, showed a relatively low rate of abnormal colposcopic findings.
A comparison of diagnoses based upon cytology with those based upon histological examination following conization are shown in Table 5 . With regard to carcinoma in situ accurate cytological diagnoses were possible in 22 out of 29 A-type cases (76%), 30 out of 44 B-type cases (68%) and 7 out of 18 C-type cases (39%). However, the results of cytology in patients having carcinoma in situ and microinvasive carcinoma were found to be only suspicious of malignancy in 26 of the 130 cases (20%).
A comparison of diagnoses by target biopsy and Ionization is shown in Table   6 . With regard to carcinoma in situ, agreement in the diagnosis was obtained in Tables 7, 8 , and 9 according to the location of the lesion. From these tables, it is apparent that underdiagnosis using cytology and target biopsy relative to conization occurred in 1 out of 31 A-type cases (Table 7) , 13 out of 71 B-type cases (Table 8 ) and 5 out of 28 C-type cases (Table 9 ) . In 9 out of the 13 underdiagnosed B-type lesions, the lesion could be viewed only partially using the colposcope, and in any of the 5 underdiagnosed C-type lesions, the entire lesion could not be seen. Abbreviations are the same as in Table 7 . ( ), number of cases. Abbreviations are the same as in Table 7 . ( ), number of cases.
DISCUSSION
Originally, colposcopy and cytology were used as supplemental diagnostic techniques in diagnosing cervical malignant tumors. Consequently, it has been accepted to use cytology to verify the presence of malignant changes and to use colposcopy to find its location. Nonetheless, due to the recent progress in cytological diagnostic techniques, it has become possible to make a high proportion of accurate histological diagnoses using cytology alone. The rate of false negative diagnosis of carcinoma in situ or microinvasive carcinoma based upon cervical scrapings with a wooden spatula does not exceed 1 or 2% (Yajima et al. 1972) . In other words, nearly all of these lesions can be detected by cytology. However, the agreement between histological and cytological diagnoses remains at the 46 to 80% level (Chao et al. 1969) . In cases where lesions are located on the ectocervix, the rate of agreement between cytological and histological diagnoses is higher, as seen in Table 5 .
In cases of carcinoma in situ or microinvasive carcinoma, the rate of abnormal colposcopical findings reaches 80 to 97% (Limburg 1958; Navratil et al. 1958; Donohue and Meriwether 1972; Stafl and Mattingly 1973; Hovadhanakul et al. 1976; Nishimura 1976 ), but the rate of being able to see the entire lesion is com monly low, here being 56% and 66% (Hollyock and Chanen 1972; Chanen and Hollyock 1974). The primary cause for this is that the lesion extends into the cervical canal or is limited to the endocervix.
The agreement between diagnosis by punch biopsy and conization or diagnosis based upon samples of hysterectomy is, as indicated by many authors, higher in target biopsy with colposcopy than in punch biopsy without colposcopy (Ortiz et al. Lesions of the ectocervix (which all gynecologists can safely diagnose by finding colposcopic ectopy of the entire area outside the external os of the uterus) which are identified as carcinoma in situ by cytology and target biopsy were all diagnosed as carcinoma in situ by conization, as shown in Table 7 . Consequently, for these cases conization can be safely avoided and the definitive treatment of carcinoma in situ can be performed (Tovell et al. 1976 ). As mentioned above, conization could be ultimately avoided in 19 of the 29 cases (66%) with lesions limited to the ectocervix. In at least 19 of the 91 carcinoma in situ cases (21%) (questions concerning the location of the lesion aside) or, in roughly 20% of the carcinoma in situ cases connization can be avoided and accurate diagnosis obtained using only cytology and target biopsy. 
